New test successfully identifies life-threatening heart disease

"A study led by investigators at Beth Israel Deaconess Medical Center has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine, the new findings offer the possibility of a highly sensitive and specific means of identifying this life-threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator" Physorg.com